Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03984097 |
Title | A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM) |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Millennium Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Alabama Oncology | Birmingham | Alabama | 35211 | United States | Details | |
Pacific Cancer Care | Monterey | California | 93940 | United States | Details | |
American Oncology Partners of Maryland, PA | Bethesda | Maryland | 20817 | United States | Details | |
Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
Levine Cancer Institute | Charlotte | North Carolina | 28204 | United States | Details | |
Good Samaritan Hospital | Cincinnati | Ohio | 45220 | United States | Details | |
Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details |